CombiMatrix Cuts Loss as Q4 Revenues Rise | GenomeWeb
This article has been updated to include news of a court award to CombiMatrix and a stock quote.
 
NEW YORK (GenomeWeb News) – CombiMatrix today reported that its fourth-quarter revenues more than doubled and the firm cut its net loss 22.2 percent as it continued its transition to focusing on molecular diagnostics.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.